Suchergebnisse - "Kim, Hyo Sun"

PubPharm (89)

1

Synthesis of site-specific Fab-drug conjugates using ADP-ribosyl cyclases

enthalten in: Protein science : a publication of the Protein Society | 2024

von Kim, H. | Hariri, K. | Zhang, X. | +5

2

Synthesis of site‐specific Fab‐drug conjugates using ADP‐ribosyl cyclases

enthalten in: Protein Science | 2024

von Kim, H. | Hariri, K. | Zhang, X. | +5

3

Generation of Bispecific Antibodies by Functionalized Poly-ADP-Ribose Polymers

enthalten in: Current protocols | 2023

von Kim, H. | Zhang, Y.

4

Nectin-4 as a Predictive Marker for Poor Prognosis of Endometrial Cancer with Mismatch Repair Impairment

enthalten in: Cancers | 2023

von Chang, H. | Park, Y. | Choi, J. | +7

5

Epidemiologic and Clinical Outcomes of Pediatric Renal Tumors in Korea : A Retrospective Analysis of The Korean Pediatric Hematology and Oncology Group (KPHOG) Data

enthalten in: Cancer research and treatment | 2023

von Koh, K. | Han, J. | Choi, H. | +46

6

Prognostic value of β-Arrestins in combination with glucocorticoid receptor in epithelial ovarian cancer

enthalten in: Frontiers in oncology | 2023

von Ryu, J. | Shin, H. | Kim, H. | +6

7

The Efficacy of Alternate Systemic Intravenous Chemotherapy and Intra-arterial Chemotherapy Approach for Eye Globe Salvage in Retinoblastoma

enthalten in: Cancer research and treatment | 2023

von Han, J. | Lee, C. | Hahn, S. | +7

8

A Novel TFG Mutation in a Korean Family with α-Synucleinopathy and Amyotrophic Lateral Sclerosis

enthalten in: Movement disorders : official journal of the Movement Disorder Society | 2022

von Yoo, D. | Lee, W. | Lee, S. | +7

9

Identification of Prognostic Markers of Gynecologic Cancers Utilizing Patient-Derived Xenograft Mouse Models

enthalten in: Cancers | 2022

von Shin, H. | Lee, E. | Yang, W. | +4

10

A Novel TFG Mutation in a Korean Family withα‐Synucleinopathy and Amyotrophic Lateral Sclerosis

enthalten in: Movement Disorders | 2022

von Yoo, D. | Lee, W. | Lee, S. | +7

1
2
3
4
5
6
7
8
9
Nächster »
[9]